Nov. 19 at 1:43 PM
$QSI Among other advances, the management team will provide updates on:
Proteus™ platform development including recent development data
A long-term technology roadmap that addresses the path to billions of reads
The path to coverage of all 20 amino acids
A suite of post-translational modification (PTM) methods enabled by the Company’s core technology
The path to Proteus commercial launch including timeline and key technical and commercial milestones
Hawkins continued, “In addition to our significant platform development progress, through various collaborations, applications of state-of-the-art computational tools, and our rich set of proprietary training data, we have unlocked an accelerated path to detecting all 20 amino acids in the very near term. And finally, we will present data regarding multiple methods in development to enable very high proteome-wide PTM coverage in combination with the significant sequencing output and performance gains of Proteus.”
$NVDA $RGTI $NAUT $SPY
